Metastatic Prostate Neuroendocrine Carcinoma
4 clinical trials · Condition
◉ Watch Metastatic Prostate Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (NCT04709276) | Andrew J. Armstrong, MD | 2021-06-07 |
| Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer (NCT04592237) | M.D. Anderson Cancer Center | 2020-12-29 |
Track Metastatic Prostate Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.